Business Description
Svas Biosana SpA
ISIN : IT0005469264
Total Employee Number:
348Description
Svas Biosana SpA operates in the production and distribution of medical device.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.17 | |||||
Debt-to-EBITDA | 4.12 | |||||
Interest Coverage | 3.16 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.84 | |||||
Beneish M-Score | -2.12 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.7 | |||||
3-Year EBITDA Growth Rate | 20.3 | |||||
3-Year EPS without NRI Growth Rate | 17.6 | |||||
3-Year Book Growth Rate | 8.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 4.41 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.22 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.54 | |||||
9-Day RSI | 54.72 | |||||
14-Day RSI | 52.64 | |||||
3-1 Month Momentum % | 10.69 | |||||
6-1 Month Momentum % | 16.5 | |||||
12-1 Month Momentum % | 15.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.85 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 143.21 | |||||
Days Sales Outstanding | 135.28 | |||||
Days Payable | 135.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.16 | |||||
Dividend Payout Ratio | 0.18 | |||||
Forward Dividend Yield % | 2.16 | |||||
5-Year Yield-on-Cost % | 2.22 | |||||
3-Year Average Share Buyback Ratio | 1.1 | |||||
Shareholder Yield % | -19 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.62 | |||||
Operating Margin % | 9.21 | |||||
Net Margin % | 4.78 | |||||
EBITDA Margin % | 13.46 | |||||
FCF Margin % | -4.02 | |||||
OCF Margin % | 4.54 | |||||
ROE % | 10.42 | |||||
ROA % | 3.83 | |||||
ROIC % | 8.16 | |||||
3-Year ROIIC % | 11.64 | |||||
ROC (Joel Greenblatt) % | 15.67 | |||||
ROCE % | 12.4 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 7.05 | |||||
Forward PE Ratio | 7.28 | |||||
PE Ratio without NRI | 6.43 | |||||
Price-to-Owner-Earnings | 14.15 | |||||
PEG Ratio | 0.35 | |||||
PS Ratio | 0.34 | |||||
PB Ratio | 0.7 | |||||
Price-to-Tangible-Book | 0.99 | |||||
Price-to-Operating-Cash-Flow | 7.33 | |||||
EV-to-EBIT | 7.74 | |||||
EV-to-EBITDA | 5.39 | |||||
EV-to-Revenue | 0.73 | |||||
EV-to-FCF | -17.64 | |||||
Price-to-GF-Value | 0.96 | |||||
Price-to-Projected-FCF | 0.89 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.35 | |||||
Price-to-Graham-Number | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 2.48 | |||||
Earnings Yield (Greenblatt) % | 12.94 | |||||
FCF Yield % | -11.8 | |||||
Forward Rate of Return (Yacktman) % | 17.71 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Svas Biosana SpA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 141.544 | ||
| EPS (TTM) (€) | 1.286 | ||
| Beta | 0.809 | ||
| 3-Year Sharpe Ratio | 0.15 | ||
| 3-Year Sortino Ratio | 0.23 | ||
| Volatility % | 28.35 | ||
| 14-Day RSI | 52.64 | ||
| 14-Day ATR (€) | 0.200623 | ||
| 20-Day SMA (€) | 9.259 | ||
| 12-1 Month Momentum % | 15.92 | ||
| 52-Week Range (€) | 7.68 - 10.8 | ||
| Shares Outstanding (Mil) | 5.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Svas Biosana SpA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Svas Biosana SpA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| EUR 0.200000 Cash Dividend | 2026-06-01 | 9.08 (+0.89%) | ||
| EUR 0.250000 Cash Dividend | 2025-06-09 | 8.32 (-0.95%) |
Show
Entries
Svas Biosana SpA Frequently Asked Questions
What is Svas Biosana SpA(MIL:SVS)'s stock price today?
The current price of MIL:SVS is €9.24. The 52 week high of MIL:SVS is €10.80 and 52 week low is €7.68.
When is next earnings date of Svas Biosana SpA(MIL:SVS)?
The next earnings date of Svas Biosana SpA(MIL:SVS) is .
Does Svas Biosana SpA(MIL:SVS) pay dividends? If so, how much?
The Dividend Yield %  of Svas Biosana SpA(MIL:SVS) is 2.16% (As of Today), Highest Dividend Payout Ratio of Svas Biosana SpA(MIL:SVS) was 0.25. The lowest was 0.18. And the median was 0.21. The  Forward Dividend Yield % of Svas Biosana SpA(MIL:SVS) is 2.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Svas Biosana SpA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers